相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
Robert Pirker et al.
LANCET ONCOLOGY (2012)
Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma
Na Zhan et al.
MEDICAL ONCOLOGY (2012)
Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non Small Cell Lung Cancer
Anastasios Dimou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?
Sylvie Lorenzen et al.
CURRENT OPINION IN ONCOLOGY (2011)
Identification of EGFR and KRAS mutations in Chinese patients with esophageal squamous cell carcinoma
Q. -W. Liu et al.
DISEASES OF THE ESOPHAGUS (2011)
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence
C. Gridelli et al.
LUNG CANCER (2011)
Trastuzumab In HER2-Positive Metastatic Gastric Cancer
Jamie D. Croxtall et al.
DRUGS (2010)
EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPY OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Mark E. Sharafinski et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry
Yukie Sato-Kuwabara et al.
BMC CANCER (2009)
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis
Mario Scartozzi et al.
BMC CANCER (2009)
Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
Pierre Laurent-Puig et al.
CLINICAL CANCER RESEARCH (2009)
ErbB receptors in the biology and pathology of the aerodigestive tract
Sarah Morgan et al.
EXPERIMENTAL CELL RESEARCH (2009)
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
Pierre Laurent-Puig et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
PI3K/PTEN signaling in tumorigenesis and angiogenesis
Bing-Hua Jiang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number
Antoine Italiano et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
The HER family and cancer: emerging molecular mechanisms and therapeutic targets
Natalia V. Sergina et al.
TRENDS IN MOLECULAR MEDICINE (2007)
STAT-mediated EGFR signaling in cancer
Kelly M. Quesnelle et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras
Seok-Hyun Kim et al.
CANCER RESEARCH (2006)
Epidermal growth factor receptor mutation testing in the care of lung cancer patients
Lecia V. Sequist et al.
CLINICAL CANCER RESEARCH (2006)
Validating cancer drug targets
John D. Benson et al.
NATURE (2006)
EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus
M Hanawa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Diagnostic evaluation of HER-2 as a molecular target: An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials
MF Press et al.
CLINICAL CANCER RESEARCH (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations of the BRAF gene in squamous cell carcinoma of the head and neck
A Weber et al.
ONCOGENE (2003)
分享论文
